top of page

OUR RESEARCH FOCUS

Our research group aims to understand how stem cells react and adapt to stress, and decipher how the microenvironment contributes to cancer progression and relapse. Furthermore, we aim to identify unique and previously unknown biological weaknesses in malignant cells, with the ultimate goal of developing innovative therapeutic strategies to improve outcomes for patients living with cancer, with a particular focus on leukemia. 

Latest News

Apr 5, 2023

Collaborative work on novel gene therapy for multiple sclerosis

Delivery of Nogo receptor(1-310)-Fc, a therapeutic fusion protein has been successfully applied as a treatment in animal models of spinal cord injury, as a novel gene therapy for multiple sclerosis

Collaborative work on novel gene therapy for multiple sclerosis

Mar 23, 2023

New research on the role of STAT5 in aggressive leukemia

Aberrant activation of the protein STAT5 is frequently observed in aggressive forms of ALL. A team of CCMR principal investigators found STAT5 accelerates ALL progression & promotes tumour resistance to chemotherapy

New research on the role of STAT5 in aggressive leukemia

Our Partners

logo-cancercare.png
CCMBF.png
University-of-manitoba-logo.svg.png
cropped-CHRIM_logo_4c_RGB__2x-full-colour.png
Iconic bridge gracing the Winnipeg downtown skyline.jpg

Winnipeg

Want to join?

bottom of page